- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Beckman Coulter Inc. (BEC)
by latest | most commented
-
Why I'm Upping Corning and Beckman Coulter Stakes
-
Healthcare: Branded Pharma Out, Diagnostics / Generics In
-
81 Dividend Growers to Consider
-
Hedge Fund Eton Park Saw Golden Opportunities in Q109
-
'TechCheck' for Top Rated U.S. Stocks
-
40 Stocks That Have Defied the Downturn
-
Eric Mindich's Eton Park Capital Likes Gold
-
Wednesday's Options Recap
-
Hedge Fund Portfolio Tracking: Andreas Halvorsen's Viking Global, Q4 2008
-
Create Your Own Diagnostics ETF
-
Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
-
Landauer Has Been Sufficiently Rewarded by the Market
-
Hedge Fund Tracking: Eton Park Capital (Eric Mindich), Q3 2008
-
Hedge Fund Tracking: Andreas Halvorsen's Viking Global, Q3 2008
-
What Are Some of the Best Hedge Fund Managers Doing?
-
Monday Options Update: C, MYGN, TSN, LLTC, F, GM, BEC, RNWK
-
PowerHouse Week for Economic Calendar
-
Inverness Tops Beckman Coulter's Bid For Biosite
-
Biotech In Review: Bidding War Erupts For Biosite
-
Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
-
Beckman Coulter Faces Criticism and a Credit Review after Biosite Announcement
-
Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
-
Beckman Coulter to Acquire Biosite Inc. for $1.55 Billion
-
Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis
-
The Red Hot Market for Medical Devices in China
-
Chinese Medical Devices IPO: Highlights from Mindray's SEC Filing
-
Analyst Upgrades & Downgrades for Monday July 24, 2006